Article
TSNAdb: A Database for Tumor-Specific Neoantigens from Immunogenomics Data Analysis
1 Aug 2018
Abstract excerpt
Tumor-specific neoantigens have attracted much attention since they can be used as biomarkers to predict therapeutic effects of immune checkpoint blockade therapy and as potential targets for cancer immunotherapy. In this study, we developed a comprehensive tumor-specific neoantigen database (TSNAdb v1.0), based on pan-cancer immunogenomic analyses of somatic mutation data and human leukocyte antigen (HLA) allele...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
